Abstract
ABSTRACTFour polyurethanes that were synthesized with different hard segments as well as four commercial polyurethanes were investigated for in-vivo biostability. The four polyurethanes with the varying hard segments were based on a 3/2/1/ mole ratio of methylene diphenylene diisocyanate (MDI) or methylene dicyclohexylene diisocyanate (H12MDI); butanediol (BD) or ethylene diamine (ED); and polytetramethylene oxide (PTMO) (MW=I000). Two commercial polyurethanes were also used: Biomer (Ethicon, Inc.) and Pellethane (Dow).Films of the polymers were implanted subcutaneously in rats for up to three months to assess their biostability. Polymer films were implanted with either a 100% strain applied or in the unstressed state. Measurement of tensile properties and surface properties before and after implantation was used to assess the stability of each of the polymers. Surface cracking was observed with scanning electron microscopy and the extent and depth of cracking was determined.It was found that BD chain extended polymers maintained their tensile properties better than the ED chain extended polymers after implantation. H12MDI-based polyurethanes were more susceptible to surface cracking than MDI-based polyurethanes, possibly due to the lack of a crystallizable hard segment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.